Pieter Van Vlierberghe

Ghent University Hospital — Belgium

Medicine · Health Sciences

52h-index12.3kcitations410works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(136), Acute Myeloid Leukemia Research(93), Epigenetics and DNA Methylation(78), CAR-T cell therapy research(68), RNA modifications and cancer(66)

Publications410 total

<i>QKI</i> dysregulation induces extensive splicing changes in T-cell acute lymphoblastic leukemia
Haematologica·2026Open Access
Benchmarking the paediatric <scp>T</scp> ‐cell <scp>ALL</scp> subtype classifier, <scp>TALLSorts</scp>
British Journal of Haematology·2025Open Access
Sox11-induced reprogramming of B2 cells to a B1a-like phenotype promotes Mantle Cell Lymphoma in mice
Blood·2025
Modeling of glucocorticoid resistance in multiple myeloma reveals mechanisms and markers of glucocorticoid resistance
Biomedicine & Pharmacotherapy·2025Open Access
Editor’s Note: A Novel <scp>L</scp>-Asparaginase with low <scp>L</scp>-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias <i>In Vivo</i>
Cancer Research·2025Open Access
Profiling histone post-translational modifications to identify signatures of epigenetic drug response in T-cell acute lymphoblastic leukemia
2025Open Access
Epigenetic Rewiring of Protein Kinase Signalling in T-Cell Acute Lymphoblastic Leukaemia
Kinases and Phosphatases·2025· 1 citedOpen Access
Stress attenuation by the adrenergic-specific lncRNA NESPR prevents cell death in neuroblastoma cells
2025· 1 cited
CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy
Pharmacological Research·2025· 1 citedOpen Access
A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models
Cancer Letters·2024· 6 citedOpen Access
CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy
2024Open Access
Depletion of the RNA binding protein QKI and circular RNA dysregulation in T-cell acute lymphoblastic leukemia
Haematologica·2024· 1 citedOpen Access
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia
Science Advances·2024· 6 citedOpen Access
Focal deletions of a promoter tether activate the <i>IRX3</i> oncogene in T-cell acute lymphoblastic leukemia
Blood·2024· 5 citedOpen Access
BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1
Haematologica·2024· 7 citedOpen Access
3187 – IKAROS LOSS ENHANCES PRE-LEUKEMIC THYMOCYTE SELF-RENEWAL AND DRIVES T-ALL IN MICE
Experimental Hematology·2024
<i>Tet2</i> is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia
Blood Advances·2024· 1 citedOpen Access
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T‐cell lymphoblastic leukemia
HemaSphere·2024· 3 citedOpen Access
Focal Deletions of a Promoter Tether Activate the <i>IRX3</i> Oncogene in T Cell Acute Lymphoblastic Leukemia
2024Open Access
A Human-Like Glutaminase-Free Asparaginase is Highly Efficacious in Asnslow Leukemia and Solid Cancer Mouse Xenograft Models
SSRN Electronic Journal·2024· 2 citedOpen Access
page 1 of 21Next →

Frequent Co-authors

Tom Taghon(16), Frank Speleman(13), Steven Goossens(13), Adolfo A. Ferrando(11), Jules P.P. Meijerink(11), Elisabeth Paietta(10), Joni Van der Meulen(9), Barbara De Moerloose(9), Yves Benoît(9), Bruce Poppe(8), Sofie Peirs(8), Tim Lammens(8), Jacob M. Rowe(7), Jean Soulier(7), Nadine Van Roy(7), Geert Berx(7), Wouter Van Loocke(7), Rob Pieters(6), H. Berna Beverloo(6), Niels Vandamme(6)